Cargando…
Identifiability of Biologicals in Adverse Drug Reaction Reports Received From European Clinical Practice
Biologicals are established treatment options that require pharmacovigilance adapted to their specific nature, including the need for products to be identifiable up to the specific manufacturer in reports of adverse drug reactions (ADRs). This study explored the identifiability of 10 classes of simi...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590109/ https://www.ncbi.nlm.nih.gov/pubmed/30460997 http://dx.doi.org/10.1002/cpt.1310 |